Active ingredientCabergolineCat. No. P-C002-001CAS 81409-90-7Family · Pharmaceutical analytical standards
Cabergoline
A dopamine agonist derived from ergot alkaloids, synthesised in Milan around 1980 and on the market since the early 1990s: it is used for excess prolactin, prolactinomas and Parkinson's disease. This family brings together the active ingredient, pharmacopoeial impurities, labelled standards, nitrosamines and other impurities.
Did you know?It has a very long half-life, of almost three days, allowing widely spaced doses. In veterinary medicine it is used to treat false pregnancy in female dogs.
Go to the active ingredient →Active ingredientCabergolineCat. No. P-C002-001CAS 81409-90-7
Pharmacopoeial impurityCabergoline EP Impurity ACat. No. P-C002-002CAS 81409-74-7
Pharmacopoeial impurityCabergoline EP Impurity BCat. No. P-C002-003CAS 166533-36-4
Pharmacopoeial impurityCabergoline EP Impurity CCat. No. P-C002-004CAS 126554-50-5
Pharmacopoeial impurityCabergoline EP Impurity DCat. No. P-C002-005CAS 85329-86-8
Isotopically labelledCabergoline Isomer-d6Cat. No. P-C002-006
Isotopically labelledCabergoline-d6Cat. No. P-C002-007CAS 2738376-76-4
NitrosamineN-Nitroso desmethyl CabergolineCat. No. P-C002-008
NitrosamineN1-Nitroso CabergolineCat. No. P-C002-009
Impurity(8S)-CabergolineCat. No. P-C002-010CAS 856676-33-0
ImpurityCabergoline Impurity 1Cat. No. P-C002-011
ImpurityCabergoline IsomerCat. No. P-C002-012CAS 81409-91-8
ImpurityCabergoline N-OxideCat. No. P-C002-013No product matches your search.
EDQM standards 1
The official European Pharmacopoeia standards for this family.
Reference substanceCabergoline CRSEDQM code Y0000472Family CabergolineNeed a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.